In conclusion, our findings demonstrate that MMPP has a potent therapeutic ability by inactivating STAT3 in LPS-treated mice AD model through inhibition of STAT3, which could result in the inhibition of Aβ accumulation by attenuating β-secretase activity. This evidence concerns the gene STAT3 and Alzheimer disease.